Connect Biopharma Holdings Limited (CNTB) vs InterCure Ltd. (INCR)

A side-by-side comparison of Connect Biopharma Holdings Limited and InterCure Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CNTB vs INCR

growth of $100 · dividends reinvested · last 6y
CNTB -95.1% (-39.6%/yr)INCR -33.9% (-6.7%/yr)INCR compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020222023202420252026$5$66
CNTB INCR

CNTB vs INCR: by the numbers

  • •INCR is the larger company ($63M vs $59M market cap).
  • •Both run net losses; INCR's is the smaller (-13.72% vs -86687.50% net margin).

Metrics side by side

Valuation

MetricCNTBINCR
P/S ratioN/A0.79
P/B ratio2.210.51
FCF yieldN/A11.64%

Profitability

MetricCNTBINCR
Gross margin100.00%14.40%
Operating margin-90740.62%2.49%
Net margin-86687.50%-13.72%
ROE-132.16%-8.80%
ROIC-136.77%-4.72%

Growth (annualized)

MetricCNTBINCR
Revenue CAGR (5Y)N/A32.71%
Total return CAGR (5Y)-47.22%-30.85%

Frequently asked

How have CNTB and INCR total returns compared?
Over the past 5 years, CNTB delivered -47.22% and INCR delivered -30.85% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.